News from can-fite biopharma A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

Dec 22, 2014, 07:00 ET

Can-Fite Doses First Patient in Global Phase II Liver Cancer Trial for CF102

 Can-Fite BioPharma Ltd. (NYSE MKT: CANF) (TASE: CFBI), a biotechnology company advancing a pipeline of proprietary small molecule drugs that...

Dec 15, 2014, 07:02 ET

Second Part of the Glaucoma Phase II study has been Approved in a European Country

 Can-Fite BioPharma Ltd. (TASE: CFBI), (NYSE MKT: CANF), a biotechnology company developing a pipeline of small...

Dec 09, 2014, 07:00 ET

Can-Fite to Initiate the Development Program of its Next Generation Drug CF602

 Can-Fite BioPharma Ltd. (NYSE MKT: CANF) (TASE:CFBI), a biotechnology company with a pipeline of proprietary small molecule drugs that address...

Dec 02, 2014, 17:49 ET

Can-Fite Announces $8 Million At-The-Market Registered Direct Offering

Can-Fite BioPharma Ltd. (NYSE MKT: CANF) (CFBI.TA),a biotechnology company advancing a pipeline of proprietary small molecule drugs that address...

Dec 01, 2014, 07:00 ET

Can-Fite Reports Financial Results for Nine Months Ended September 30, 2014

 Can-Fite BioPharma Ltd. (NYSE MKT: CANF) (TASE: CFBI), a biotechnology company with a pipeline of proprietary small molecule drugs that...

Dec 01, 2014, 07:00 ET

US Researchers Published Scientific Findings that are a Potential Breakthrough for Prevention of Neuropathic Pain by CF101

Can-Fite BioPharma Ltd. (NYSE MKT: CANF) (TASE:CFBI), a biotechnology company with a pipeline of proprietary small molecule drugs that address...

Nov 18, 2014, 07:00 ET

Can-Fite Near-Term Milestones Timetable for 2014/2015

 Can-Fite BioPharma Ltd. (NYSE MKT: CANF) (TASE: CFBI), a biotechnology company advancing a pipeline of proprietary small molecule drugs that...

Nov 17, 2014, 17:48 ET

Can-Fite Announces Special General Meeting of Shareholders to Elect External Director

Can-Fite BioPharma Ltd. (NYSE MKT: CANF) (TASE: CFBI), a biotechnology company advancing a pipeline of proprietary small molecule drugs that...

Nov 13, 2014, 07:00 ET

Can-Fite CEO Dr. Pnina Fishman to Present Recently Released Positive Data from its Rheumatoid Arthritis Phase IIb Study at the 2014 American College of Rheumatology Annual Meeting

Can-Fite BioPharma Ltd. (NYSE MKT: CANF) (TASE: CFBI), a biotechnology company advancing a pipeline of proprietary small molecule drugs that...

Oct 30, 2014, 07:00 ET

Can-Fite to Participate in BIO-Europe International Partnering Conference

 Can-Fite BioPharma Ltd. (NYSE MKT: CANF) (TASE: CFBI), a biotechnology company advancing a pipeline of proprietary small molecule drugs that...

Oct 07, 2014, 07:00 ET

Can-Fite CEO Dr. Pnina Fishman to Co-Chair and Present at the 19th World Congress on Advances in Oncology's Cancer Therapeutics Session

 Can-Fite BioPharma Ltd. (NYSE MKT: CANF) (TASE: CFBI), a biotechnology company advancing a pipeline of proprietary small molecule drugs that...

Sep 30, 2014, 07:00 ET

U.S. Patent and Trademark Office Issues Can-Fite Patent for CF102 in the Treatment of Liver Regeneration and Function Following Surgery

 Can-Fite BioPharma Ltd. (NYSE MKT: CANF) (TASE: CFBI), a biotechnology company advancing a pipeline of proprietary small molecule drugs that...

Sep 17, 2014, 15:02 ET

Can-Fite Files June 30, 2014 Interim Financial Statements

 Can-Fite BioPharma  Ltd. (TASE:CFBI), (NYSE MKT:CANF),  a biotechnology company with a pipeline of proprietary small molecule...

Sep 17, 2014, 07:00 ET

Can Fite's Drug CF101 is Presented in Scientific Journal as One of Four Small Molecule Drugs for the Treatment of Psoriasis

 Can-Fite BioPharma Ltd. (NYSE MKT: CANF) (TASE: CFBI), a biotechnology company advancing a pipeline of proprietary small molecule drugs that...

Sep 05, 2014, 07:00 ET

Can-Fite Issued Japanese Patent for CF102 in the Treatment of Liver Regeneration and Function Following Surgery

 Can-Fite BioPharma Ltd. (NYSE MKT: CANF) (TASE: CFBI), a biotechnology company advancing a pipeline of proprietary small molecule drugs that...

Sep 03, 2014, 07:00 ET

Can-Fite to Present at Rodman & Renshaw Global Investment Conference in New York City on September 9, 2014

 Can-Fite BioPharma Ltd. (NYSE MKT: CANF) (TASE:CFBI), a biotechnology company with a pipeline of proprietary small molecule drugs that address...

Sep 02, 2014, 07:00 ET

Can-Fite Reports First Six Months 2014 Results

 Can-Fite BioPharma Ltd. (NYSE MKT: CANF) (TASE: CFBI), a biotechnology company with a pipeline of proprietary small molecule drugs that...

Aug 06, 2014, 07:00 ET

New Data Shows High Efficacy for Can-Fite's CF101 in Rheumatoid Arthritis and Psoriasis Patients

 Can-Fite BioPharma Ltd. (NYSE MKT: CANF) (TASE:CFBI), a biotechnology company with a pipeline of proprietary small molecule drugs that address...

Jul 21, 2014, 07:00 ET

Can-Fite CEO to Deliver Scientific Presentation and Serve on Expert Panel at Purines 2014 in Bonn, Germany on July 23-27, 2014

 Can-Fite BioPharma Ltd. (NYSE MKT: CANF) (TASE: CFBI), a biotechnology company with a pipeline of proprietary small molecule drugs that...

Jul 10, 2014, 07:00 ET

Can-Fite's CF102 Approved for Compassionate Use in Israel for Liver Cancer Patient

 Can-Fite BioPharma Ltd. (NYSE MKT: CANF) (TASE: CFBI), a biotechnology company with a pipeline of proprietary small molecule drugs that...